#dna_damage — Public Fediverse posts
Live and recent posts from across the Fediverse tagged #dna_damage, aggregated by home.social.
-
DATE: July 17, 2026 at 12:19AM
SOURCE: SCIENCE DAILY MIND-BRAIN FEEDTITLE: New Alzheimer's drug repairs DNA damage and reduces brain inflammation
URL: https://www.sciencedaily.com/releases/2026/07/260711010118.htm
A drug originally developed for spinal cord injury may offer a fresh approach to treating Alzheimer’s disease. In mouse studies, KCL-286 repaired dangerous DNA damage, reduced inflammation, and targeted multiple disease-related pathways instead of focusing on just amyloid or tau. Since it has already cleared an initial human safety trial, researchers believe it could move more quickly into Alzheimer’s clinical testing.
URL: https://www.sciencedaily.com/releases/2026/07/260711010118.htm
-------------------------------------------------
Private, vetted email list for mental health professionals: https://www.clinicians-exchange.org
Unofficial Psychology Today Xitter to toot feed at Psych Today Unofficial Bot @PTUnofficialBot
-------------------------------------------------
#psychology #counseling #socialwork #psychotherapy @psychotherapist @psychotherapists @psychology @socialpsych @socialwork @psychiatry #mentalhealth #psychiatry #healthcare #depression #psychotherapist #AlzheimersDrug #DNARepair #Neuroinflammation #KCL286 #AlzheimersResearch #DNA_damage #BrainHealth #NeurodegenerativeDisease #ClinicalTrials #DrugRepurposing
-
DATE: July 17, 2026 at 12:19AM
SOURCE: SCIENCE DAILY MIND-BRAIN FEEDTITLE: New Alzheimer's drug repairs DNA damage and reduces brain inflammation
URL: https://www.sciencedaily.com/releases/2026/07/260711010118.htm
A drug originally developed for spinal cord injury may offer a fresh approach to treating Alzheimer’s disease. In mouse studies, KCL-286 repaired dangerous DNA damage, reduced inflammation, and targeted multiple disease-related pathways instead of focusing on just amyloid or tau. Since it has already cleared an initial human safety trial, researchers believe it could move more quickly into Alzheimer’s clinical testing.
URL: https://www.sciencedaily.com/releases/2026/07/260711010118.htm
-------------------------------------------------
Private, vetted email list for mental health professionals: https://www.clinicians-exchange.org
Unofficial Psychology Today Xitter to toot feed at Psych Today Unofficial Bot @PTUnofficialBot
-------------------------------------------------
#psychology #counseling #socialwork #psychotherapy @psychotherapist @psychotherapists @psychology @socialpsych @socialwork @psychiatry #mentalhealth #psychiatry #healthcare #depression #psychotherapist #AlzheimersDrug #DNARepair #Neuroinflammation #KCL286 #AlzheimersResearch #DNA_damage #BrainHealth #NeurodegenerativeDisease #ClinicalTrials #DrugRepurposing
-
DATE: July 17, 2026 at 12:19AM
SOURCE: SCIENCE DAILY MIND-BRAIN FEEDTITLE: New Alzheimer's drug repairs DNA damage and reduces brain inflammation
URL: https://www.sciencedaily.com/releases/2026/07/260711010118.htm
A drug originally developed for spinal cord injury may offer a fresh approach to treating Alzheimer’s disease. In mouse studies, KCL-286 repaired dangerous DNA damage, reduced inflammation, and targeted multiple disease-related pathways instead of focusing on just amyloid or tau. Since it has already cleared an initial human safety trial, researchers believe it could move more quickly into Alzheimer’s clinical testing.
URL: https://www.sciencedaily.com/releases/2026/07/260711010118.htm
-------------------------------------------------
Private, vetted email list for mental health professionals: https://www.clinicians-exchange.org
Unofficial Psychology Today Xitter to toot feed at Psych Today Unofficial Bot @PTUnofficialBot
-------------------------------------------------
#psychology #counseling #socialwork #psychotherapy @psychotherapist @psychotherapists @psychology @socialpsych @socialwork @psychiatry #mentalhealth #psychiatry #healthcare #depression #psychotherapist #AlzheimersDrug #DNARepair #Neuroinflammation #KCL286 #AlzheimersResearch #DNA_damage #BrainHealth #NeurodegenerativeDisease #ClinicalTrials #DrugRepurposing